Because NO not only inhibits insulin release but also stimulates glucagon release [1], [2], [3], [6], [19], [20], [21], [29] this observation thus underlined a possible pathogenic role of the islet NO system in the development of type 2 diabetes. Here, INS is linked to type 2 diabetes mellitus.